RE:RE:Some expected revenue in 2018I may be way off base here, as I know almost nothing about launching new drugs. Which Pg indication is being debated? Pg is not lipitor or viagra. PLI isn't looking to convince every GP in the country to prescribe Pg. PgD is a rare disease. Not sure how many specialists out there actually treat this patient population. I'm only guessing but it may not be that many. Also, the fact that IV Pg will be the first and only alternative to current treatment. Will it really cost that much to market? Not a rhetorical question. What are your optinions?